DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.41
+1.54 (31.62%)
At close: Dec 20, 2024, 4:00 PM
5.65
-0.76 (-11.86%)
After-hours: Dec 20, 2024, 7:58 PM EST
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $274.10 million as of December 20, 2024. Its market cap has increased by 154.26% in one year.
Market Cap
274.10M
Enterprise Value
224.26M
1-Year Change
154.26%
Ranking
Category
Stock Price
$6.41
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $274.10M, an increase of 646.85%. That is a compound annual growth rate of 39.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 274.10M | 154.27% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LifeMD | 212.23M |
| Utah Medical Products | 210.55M |
| biote | 209.29M |
| Zentalis Pharmaceuticals | 208.81M |
| Acrivon Therapeutics | 208.30M |
| SOPHiA GENETICS | 205.96M |
| ADC Therapeutics | 204.98M |
| Inhibrx Biosciences | 200.93M |